Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights From Comprehensive Multicenter Preclinical StudiesSarah‐Eve Lemay, Sébastien Bonnet, Reem El Kabbout et al.|Circulation|2025Cited by 26
Abstract 4139465: Integrin α5β1 represents a novel therapeutic target to improve vascular remodeling in pulmonary arterial hypertensionSarah‐Eve Lemay, Sébastien Bonnet, Mónica S. Montesinos et al.|Circulation|2024Cited by 1
Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights from Comprehensive Multicenter Preclinical StudiesSarah‐Eve Lemay, Sébastien Bonnet, Mónica S. Montesinos et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 0
Identification of integrin a5b1 inhibition as a potentially disease-modifying approach for the treatment of pulmonary arterial hypertensionMónica S. Montesinos, Min Lü, Sarah‐Eve Lemay et al.|Unknown|2024Cited by 0
Abstract 4139456: Integrin α5β1 contributes to pathological remodeling of the right ventricle in pulmonary arterial hypertensionSarah‐Eve Lemay, Sébastien Bonnet, Mónica S. Montesinos et al.|Circulation|2024Cited by 0